메뉴 건너뛰기




Volumn 46, Issue 6, 2005, Pages 221-227

Effects of low-dose pergolide therapy on cardiac valves in patients with Parkinson's disease

Author keywords

Doppler ultrasound; Echocardiography, transthoracic; Valvular disease (pergolide therapy, Parkinson's disease)

Indexed keywords

ANTIPARKINSON AGENT; PERGOLIDE MESILATE;

EID: 30344481661     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (11)

References (13)
  • 2
    • 0036894735 scopus 로고    scopus 로고
    • Drug-related valvular heart disease: Here go again: Will we do better this time?
    • Rahimtoola SH: Drug-related valvular heart disease: Here go again: Will we do better this time? Mayo Clin Proc 2002; 77: 1275-1277
    • (2002) Mayo Clin Proc , vol.77 , pp. 1275-1277
    • Rahimtoola, S.H.1
  • 3
    • 0038581961 scopus 로고    scopus 로고
    • The US Food and Drug Administration's registry of patients with pergolide-associated valvular heart disease
    • Rowers CM, Racoosin JA, Lu SL, Beitz JG: The US Food and Drug Administration's registry of patients with pergolide-associated valvular heart disease. Mayo Clin Proc 2003; 78: 730-731
    • (2003) Mayo Clin Proc , vol.78 , pp. 730-731
    • Rowers, C.M.1    Racoosin, J.A.2    Lu, S.L.3    Beitz, J.G.4
  • 4
    • 0038388798 scopus 로고    scopus 로고
    • Additional insights into pergolide-associated valvular heart disease
    • Lanier WL: Additional insights into pergolide-associated valvular heart disease. Mayo Clin Proc 2003; 78: 684-686
    • (2003) Mayo Clin Proc , vol.78 , pp. 684-686
    • Lanier, W.L.1
  • 7
    • 0141653014 scopus 로고    scopus 로고
    • Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide
    • Van Camp G, Flamez A, Cosyns B, Goldstein J, Perdaens C, Schoors D: Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide. Neurology 2003; 61: 859-861
    • (2003) Neurology , vol.61 , pp. 859-861
    • Van Camp, G.1    Flamez, A.2    Cosyns, B.3    Goldstein, J.4    Perdaens, C.5    Schoors, D.6
  • 10
    • 0021355452 scopus 로고
    • Mechanisms for development of functional tricuspid regurgitation determined by pulsed Doppler and two-dimensional echocardiography
    • Mikami T, Kudo T, Sakurai N, Sakamoto S, Tanabe Y, Yasuda H: Mechanisms for development of functional tricuspid regurgitation determined by pulsed Doppler and two-dimensional echocardiography. Am J Cardiol 1984; 53: 160-163
    • (1984) Am J Cardiol , vol.53 , pp. 160-163
    • Mikami, T.1    Kudo, T.2    Sakurai, N.3    Sakamoto, S.4    Tanabe, Y.5    Yasuda, H.6
  • 11
    • 0027537179 scopus 로고
    • Edema: An infrequently recognized complication of bromocriptine and other ergot dopaminergic drugs
    • Blackard WG: Edema: An infrequently recognized complication of bromocriptine and other ergot dopaminergic drugs. Am J Med 1993; 94: 445
    • (1993) Am J Med , vol.94 , pp. 445
    • Blackard, W.G.1
  • 12
    • 0034073543 scopus 로고    scopus 로고
    • Clinical characteristics of pramipexole-induced peripheral edema
    • Tan EK, Ondo W: Clinical characteristics of pramipexole-induced peripheral edema. Arch Neurol 2000; 57: 729-732
    • (2000) Arch Neurol , vol.57 , pp. 729-732
    • Tan, E.K.1    Ondo, W.2
  • 13
    • 22044452961 scopus 로고    scopus 로고
    • Valvular heart disease
    • (ed by Zipes DP, Libby P, Bonow RO, Braunwald E), 7th Ed. Elsevier Saunders, Philadelphia
    • Bonow RO, Braunwald E: Valvular heart disease, in Heart Disease (ed by Zipes DP, Libby P, Bonow RO, Braunwald E), 7th Ed. Elsevier Saunders, Philadelphia, 2004; pp 1553-1632
    • (2004) Heart Disease , pp. 1553-1632
    • Bonow, R.O.1    Braunwald, E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.